Philippines: No field testing for Bt talong

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

Philippines: No field testing for Bt talong

On December 8 2015, the Supreme Court, in a decision in four consolidated cases (GR Nos 209271, 209276, 209301 and 209430) permanently enjoined the field testing for Bt talong (genetically modified eggplant), declared the Department of Agriculture Administrative Order No 08, series of 2002 (DAO 08) as null and void, and temporarily enjoined any application for contained use, field testing, propagation, commercialisation, and importation of genetically modified organisms (GMOs) until a new administrative order is promulgated in accordance with the law.

veg

This case arose from a petition filed on April 26 2012 by Greenpeace Southeast Asia (Philippines), a regional office of Greenpeace International, a non-governmental environmental organisation known for its campaign to preserve the environment and promote peace, and some Filipino scientists, professors and ordinary citizens invoking their constitutional right, and the right of future generations of Filipinos, to health and balanced ecology. The objection was directed to the research and development project partly funded by the USAID, on eggplants that are resistant to the fruit and shoot borer.

As quoted by the Supreme Court from the field trial proposal of the project proponents, the crystal toxin genes from the soil bacterium Bacillus thuringiensis (Bt) were incorporated into the eggplant (talong) genome to produce the protein Cry1Ac which is toxic to the targeted fruit and shoot borer, the most destructive of insect pest of eggplants.

Greenpeace claimed that the required environmental compliance certificate was not obtained prior to project implementation; no independent peer-reviewed study on the safety of Bt talong for human consumption and the environment was conducted; no public consultation was made on the areas chosen for field testing, hence, the precautionary principle must be applied. The petitioners argued that the precautionary principle did not apply because the field testing is only part of a continuing study being done to ensure that the field trials have no significant and negative impact on the environment, and that the issues raised by Greenpeace involved technical matters pertaining to the special competence of the Bureau of Plant Industry (BPI) whose determination is entitled to great respect, and charged with the implementation of DAO 08 which covers the importation or release into the environment of any plant which has been altered or produced thru the use of modern biotechnology, etc and EO 514 on the National Biosafety Framework (NBF).

In its decision, the Supreme Court found that the petitioners-government agencies clearly failed to fulfil their duties in the implementation of the NBF, and held that the precautionary rule finds direct application in the evaluation of evidence presented in this case, considering that the Philippines is signatory to the Convention on Biological Diversity (CBD) and the Cartagena Protocol, a supplementary agreement to the CBD, ratified by the Philippine Congress.

The Supreme Court further stated that the precautionary principle should be treated as a principle of last resort where the application of the regular rules of evidence would cause an inequitable result for the environmental plaintiff, and when the features of uncertainty, the possibility of irreversible harm and the possibility of serious harm coincide, the case for the precautionary principle is strongest.

Hechanova_Editha-100

Editha R Hechanova


Hechanova & Co., Inc.Chemphil Bldg.851 Antonio Arnaiz AvenueMakati City 1223, PhilippinesTel: (63) 2 812-6561Fax: (63) 2 888-4290editharh@hechanova.com.ph  www.hechanova.com.ph

more from across site and SHARED ros bottom lb

More from across our site

Anita Polott, who is celebrating three decades at Morgan Lewis this year, reflects on career progression, stepping into unfamiliar territory, and leadership frameworks
Technical excellence remains essential, but many firms are discovering that packaging IP with complementary practice areas can unlock new clients and a stronger competitive position
As international interest in Southeast Asia grows, Sheng Rong Tng discusses how changing client demands and the firm’s multidisciplinary model are helping it compete for complex regional mandates
Todd Hopfinger, director in Sterne Kessler’s electronics practice group, says IP owners are contemplating how patent rights will be enforced as commercial activity expands beyond Earth
Christopher Stothers' arrival strengthens the firm's life sciences, technology and UPC offering as competition for top European litigators intensifies
Armstrong Teasdale’s Jim Heinen Jr discusses the challenge of balancing billables, business development and family life and explains why not all patent lawyers are science nerds
From cross-border jurisdiction to the end of the transitional period, Powell Gilbert’s Ioana Sabau and Bryce Matthewson predict the biggest talking points ahead
A wave of office launches and lateral hires reflects the draw of patent disputes, but booming AI, semiconductor and data centre markets are offering an even bigger IP opportunity
The hire of Frederick Nicolle as a partner continues Pinsent Masons' expansion while reducing Simmons’ patent prosecution offering in London to zero
The expansion into Granada forms part of a national ‘decentralisation’ strategy focused on providing proximity to research and tech businesses away from traditional hubs
Gift this article